Crescent Biopharma Ord Shs

Important metrics include cash and short-term investments, total assets, current assets, total liabilities, current liabilities, long-term debt, shareholders' equity, retained earnings, inventory, receivables, working capital, current ratio, quick ratio, debt-to-equity ratio, and return on equity. Investors usually review these together rather than relying on one number.

Assets are resources the company owns or controls, such as cash, receivables, inventory, investments, and property. Liabilities are obligations the company owes, such as accounts payable, debt, leases, and taxes. Shareholders' equity is the residual value after liabilities are subtracted from assets.

Current assets and current liabilities are generally expected to be converted, used, paid, or settled within one year or one operating cycle. Non-current assets and non-current liabilities are longer-term items, such as property, long-term investments, deferred tax assets, long-term debt, and lease obligations.

In its most recent quarterly, Crescent Biopharma Ord Shs had 171.59M in cash and cash equivalents.

Crescent Biopharma Ord Shs reported 37.28M in total liabilities as of the latest reported quarter, including 36.07M in current liabilities and 1.21M in non-current liabilities.

As of the latest reported quarter, Crescent Biopharma Ord Shs's total assets were 240.29M, consisting of 236.66M in current assets and 3.64M in non-current assets.

Crescent Biopharma Ord Shs reported 203.01M in total shareholders' equity as of the latest reported quarter.